Home Healthcare Biotechnology Cell-free DNA Testing Market

Cell-free DNA Testing Market Size, Share & Trends Analysis Report By Type (Cell-free Fetal DNA, Circulating Tumor DNA, Donor-derived cfDNA), By Technology (Massive Parallel Shotgun Sequencing, Targeted MP Sequencing, Single-Nucleotide Polymorphism, Digital PCR), By Application (Gynecology/Prenatal Testing, Oncology, Transplantation, Others), By End User (Clinical Laboratories, Hospitals, Research & Academic Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 20, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
  7. North America Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
  8. Europe Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
  9. APAC Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
  10. Middle East and Africa Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
  11. LATAM Cell-free DNA Testing Market Size Analysis
    1. Introduction
    2. Cell-free DNA Testing Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell-free Fetal DNA
      2. Circulating Tumor DNA
      3. Donor-derived cfDNA
    3. Cell-free DNA Testing Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Massive Parallel Shotgun Sequencing
      2. Targeted MP Sequencing
      3. Single-Nucleotide Polymorphism
      4. Digital PCR
    4. Cell-free DNA Testing Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Gynecology/Prenatal Testing
      2. Oncology
      3. Transplantation
      4. Others
    5. Cell-free DNA Testing Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Clinical Laboratories
      2. Hospitals
      3. Research & Academic Institutes
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell-free Fetal DNA
        2. Circulating Tumor DNA
        3. Donor-derived cfDNA
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Massive Parallel Shotgun Sequencing
        2. Targeted MP Sequencing
        3. Single-Nucleotide Polymorphism
        4. Digital PCR
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Gynecology/Prenatal Testing
        2. Oncology
        3. Transplantation
        4. Others
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Clinical Laboratories
        2. Hospitals
        3. Research & Academic Institutes
  12. Competitive Landscape
    1. Cell-free DNA Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Illumina, Inc. (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc. (US)
    3. Hoffmann-La Roche Ltd (Switzerland)
    4. Agilent Technologies, Inc. (US)
    5. QIAGEN N.V. (Netherlands)
    6. Guardant Health, Inc. (US)
    7. Natera, Inc. (US)
    8. Exact Sciences Corporation (US)
    9. Labcorp Holdings Inc. (US)
    10. Quest Diagnostics Incorporated (US)
    11. Myriad Genetics, Inc. (US)
    12. Foundation Medicine, Inc. (US)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.